4//SEC Filing
HICKLIN DANIEL J 4
Accession 0000899243-22-002202
CIK 0001785530other
Filed
Jan 17, 7:00 PM ET
Accepted
Jan 18, 6:31 PM ET
Size
5.5 KB
Accession
0000899243-22-002202
Insider Transaction Report
Form 4
HICKLIN DANIEL J
DirectorSee Remarks
Transactions
- Award
Stock Option (right to buy)
2022-01-06+215,888→ 215,888 totalExercise: $11.55Exp: 2032-01-05→ Common Stock (215,888 underlying)
Footnotes (1)
- [F1]The option was granted on January 6, 2022 with a Vesting Commencement Date of January 1, 2022. The shares underlying the option vest over four years, with 25% of the shares vesting on the first anniversary of the Vesting Commencement Date and 2.0833% of the shares vesting each month thereafter through January 1, 2026.
Documents
Issuer
Werewolf Therapeutics, Inc.
CIK 0001785530
Entity typeother
Related Parties
1- filerCIK 0001260929
Filing Metadata
- Form type
- 4
- Filed
- Jan 17, 7:00 PM ET
- Accepted
- Jan 18, 6:31 PM ET
- Size
- 5.5 KB